Your browser doesn't support javascript.
loading
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
Holmes, C; Ballard, C; Lehmann, D; David Smith, A; Beaumont, H; Day, I N; Nadeem Khan, M; Lovestone, S; McCulley, M; Morris, C M; Munoz, D G; O'Brien, K; Russ, C; Del Ser, T; Warden, D.
Affiliation
  • Holmes C; University of Southampton, Clinical Neurosciences Research Division, Memory Assessment and Research Centre, Moorgreen Hospital, Botley Road, Southampton, UK. c.holmes@soton.ac.uk
J Neurol Neurosurg Psychiatry ; 76(5): 640-3, 2005 May.
Article in En | MEDLINE | ID: mdl-15834019
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Butyrylcholinesterase / Cognition Disorders / Alzheimer Disease Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2005 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Butyrylcholinesterase / Cognition Disorders / Alzheimer Disease Type of study: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: J Neurol Neurosurg Psychiatry Year: 2005 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido